<?xml version="1.0" encoding="UTF-8"?>
<p>In 2014, HAdV-B7d was detected in Oregon and Illinois, USA (
 <xref rid="R11" ref-type="bibr">
  <italic>11</italic>
 </xref>
 <italic>,</italic>
 <xref rid="R12" ref-type="bibr">
  <italic>12</italic>
 </xref>). During 2016â€“2017, a total of 12 cases were reported, including 3 patients in a residential rehabilitation center, 7 college students, and 2 patients at a tertiary care hospital. Four of those 12 case-patients died; all 4 were in 3 adjacent New Jersey counties and had underlying conditions (
 <xref rid="R2" ref-type="bibr">
  <italic>2</italic>
 </xref>,
 <xref rid="R13" ref-type="bibr">
  <italic>13</italic>
 </xref>,
 <xref rid="R14" ref-type="bibr">
  <italic>14</italic>
 </xref>). In 2018, an HAdV-B7d outbreak at multiple facilities in several US regions resulted in the deaths of 11 infants at rehabilitation center in New Jersey and an 18-year-old freshman at the University of Maryland (
 <xref rid="R15" ref-type="bibr">
  <italic>15</italic>
 </xref>). In summary, HAdV-B7d transmission occurred in community and congregate settings throughout the United States, resulting in severe illness and death in some patients with underlying conditions. HAdV-B7d has been more commonly associated with severe respiratory disease and has a higher mortality rate than other HAdV types (
 <xref rid="R6" ref-type="bibr">
  <italic>6</italic>
 </xref>,
 <xref rid="R12" ref-type="bibr">
  <italic>12</italic>
 </xref>). Therefore, clinicians and public health facilitators should consider HAdV-B7d in patients with severe respiratory infections.
</p>
